247 related articles for article (PubMed ID: 22348037)
21. Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells.
Jacob DA; Bahra M; Langrehr JM; Boas-Knoop S; Stefaniak R; Davis J; Schumacher G; Lippert S; Neumann UP
J Gastroenterol Hepatol; 2007 May; 22(5):738-48. PubMed ID: 17444865
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
23. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.
Park G; Yoon BS; Moon JH; Kim B; Jun EK; Oh S; Kim H; Song HJ; Noh JY; Oh C; You S
J Invest Dermatol; 2008 Oct; 128(10):2429-41. PubMed ID: 18463684
[TBL] [Abstract][Full Text] [Related]
24. HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer.
Jung KH; Yan HH; Fang Z; Son MK; Lee H; Hong S; Hong SS
Int J Oncol; 2014 Jul; 45(1):311-21. PubMed ID: 24819705
[TBL] [Abstract][Full Text] [Related]
25. Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine.
Lankadasari MB; Aparna JS; Mohammed S; James S; Aoki K; Binu VS; Nair S; Harikumar KB
Theranostics; 2018; 8(14):3824-3840. PubMed ID: 30083262
[No Abstract] [Full Text] [Related]
26. Mechanism of the inhibition of the STAT3 signaling pathway by EGCG.
Wang Y; Ren X; Deng C; Yang L; Yan E; Guo T; Li Y; Xu MX
Oncol Rep; 2013 Dec; 30(6):2691-6. PubMed ID: 24065300
[TBL] [Abstract][Full Text] [Related]
27. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.
Huang C; Yang G; Jiang T; Huang K; Cao J; Qiu Z
J Exp Clin Cancer Res; 2010 May; 29(1):51. PubMed ID: 20482858
[TBL] [Abstract][Full Text] [Related]
28. Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells.
Ma L; Wei J; Su GH; Lin J
Cancer Biol Ther; 2019; 20(6):855-865. PubMed ID: 30866697
[TBL] [Abstract][Full Text] [Related]
29. STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract][Full Text] [Related]
30. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD
J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388
[TBL] [Abstract][Full Text] [Related]
31. EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation.
Lin CH; Chao LK; Hung PH; Chen YJ
Int J Clin Exp Pathol; 2014; 7(5):2372-81. PubMed ID: 24966947
[TBL] [Abstract][Full Text] [Related]
32. BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer.
Awasthi N; Zhang C; Ruan W; Schwarz MA; Schwarz RE
Mol Cancer Ther; 2012 Dec; 11(12):2644-53. PubMed ID: 23047891
[TBL] [Abstract][Full Text] [Related]
33. Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.
Luo F; Lu FT; Qiu MZ; Zhou T; Ma WJ; Luo M; Zeng KM; Luo QY; Pan WT; Zhang L; Xia ZF; Zhang ZH; Cao JX; Zhao HY; Zhang L; Yang DJ
Cell Death Dis; 2021 Aug; 12(8):772. PubMed ID: 34354046
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells.
Liu P; Feng J; Sun M; Yuan W; Xiao R; Xiong J; Huang X; Xiong M; Chen W; Yu X; Sun Q; Zhao X; Zhang Q; Shao L
Int J Oncol; 2017 Dec; 51(6):1878-1886. PubMed ID: 29039524
[TBL] [Abstract][Full Text] [Related]
35. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q
BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403
[TBL] [Abstract][Full Text] [Related]
36. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
Bi YL; Min M; Shen W; Liu Y
Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
[TBL] [Abstract][Full Text] [Related]
37. Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells.
Wei J; Ma L; Li C; Pierson CR; Finlay JL; Lin J
Curr Cancer Drug Targets; 2019; 19(7):571-582. PubMed ID: 30332965
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
[TBL] [Abstract][Full Text] [Related]
39. Y-27632 Increases Sensitivity of PANC-1 Cells to EGCG in Regulating Cell Proliferation and Migration.
Liu X; Bi Y
Med Sci Monit; 2016 Oct; 22():3529-3534. PubMed ID: 27694793
[TBL] [Abstract][Full Text] [Related]
40. A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling.
Cowan RW; Maitra A; Rhim AD
Gastroenterology; 2015 Dec; 149(7):1685-8. PubMed ID: 26526714
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
